Latest Regulatory Affairs Newsletter
A collection of regulatory news from this month.
Is The 2015 Nobel Prize a Turning Point for Traditional Chinese Medicine?
Half of the 2015 Nobel Prize in Physiology or Medicine went to a researcher who spent her entire career researching traditional Chinese medicine. Scientist Youyou Tu, is based at the Chinese Academy of Traditional Chinese Medicine in Beijing (now the China Academy of Chinese Medical Sciences) since 1965. Traditional medical knowledge anywhere in the world has not even been on the radar for Nobel Prize prospects. Until 2015, that is. So how should we interpret this arguably seismic shift in international attention on traditional Chinese medicine? Source: The Conversation Nobel Laureate, Youyou Tu
Courts Gag Campaigner After ‘Toxic’ Capilano Honey Remarks
A Victorian beekeeper who accused a leading Queensland honey manufacturer of selling “toxic” foreign products has been gagged by the courts ahead of legal action. (Capilano defends product safety but is slow to respond to misleading country of origin labelling after accusations of using imported Chinese honey with the local product). Source: RJ Whitehead, Food Navigator-Asia 'Toxic' honey
TGA Provides Compliance Advice and Education for Listed Medicines
The following information is aimed at providing sponsors with a better understanding of common compliance issues and how they can be avoided. The Therapeutic Goods Administration believes that sponsors want to do the right thing and hopes that this information will provide clarity around regulatory requirements so that sponsors can more easily comply with the law. Source: TGA education
Australian Firm Launches ‘World’s First Clinically Tested’ Prebiotic Honey
Australian manufacturer Capilano has launched what it states is the world’s first clinically tested prebiotic honey. Source: By Gary Scattergood, Food Navigator-Asia Prebiotic honey
TGA Updates List of 'Permissible Ingredients' for Use in Listed Medicines
The Therapeutic Goods Administration has listed the changes to ingredient availability in the amended Therapeutic Goods (Permissible Ingredients) Determination No. 2 of 2016. The list includes new allowable ingredients, Removal of one previously allowed ingredient, and, Changes to ingredient requirements. Sources: Permissible ingredient update 1 ; Permissible ingredient update 2